Insulin Pump Market Will Expand With MEMS Technology – Animas
This article was originally published in The Gray Sheet
Executive Summary
Animas aims to introduce a next-generation insulin micro-pump to the U.S. in 2007, having acquired rights to Debiotech's micro-electromechanical systems (MEMS) technology
You may also be interested in...
Animas Maps Two-Pronged Strategy For Glucose Sensor Development
Insulin pump maker Animas will pursue development of both minimally-invasive and fully implantable continuous glucose sensors under a dual strategy that could lead to creation of an artificial pancreas
Animas Maps Two-Pronged Strategy For Glucose Sensor Development
Insulin pump maker Animas will pursue development of both minimally-invasive and fully implantable continuous glucose sensors under a dual strategy that could lead to creation of an artificial pancreas
Animas Targets Profitability In 2005 Despite Insulin Pump Production Issues
Animas expects to clear up supplier issues hindering production of its IR1200 insulin pump by October, as increased demand tips the firm toward profitability in 2005, President & CEO Katherine Crothall says